Health
Trump-touted hydroxychloroquine shows no benefit in COVID-19 prevention: Study – The Jakarta Post – Jakarta Post
A malaria drug taken by US President Donald Trump to prevent COVID-19 did not show any benefit versus placebo in reducing coronavirus infection among healthcare…

A malaria drug taken by US President Donald Trump to prevent COVID-19 did not show any benefit versus placebo in reducing coronavirus infection among healthcare workers, according to clinical trial results published on Wednesday.
The study largely confirms results from a clinical trial in June that showed hydroxychloroquine was ineffective in preventing infection among people exposed to the new coronavirus.
Trump began backing hydroxychloroquine early in the pandemic and told reporters in May …
-
Noosa News18 hours ago
How Lily Steele-Park took her rapist to court and won
-
Business23 hours ago
Ford CEO makes stunning prediction about artificial intelligence
-
General24 hours ago
Rush to buy homes before rate cuts send prices soaring
-
Business20 hours ago
5 things to watch on the ASX 200 on Tuesday 8 July 2025